Effects of Vibration Training on Exercise Capacity in COPD-patients
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: whole body vibration training
- Registration Number
- NCT01380639
- Lead Sponsor
- Schön Klinik Berchtesgadener Land
- Brief Summary
The aim of this study is to investigate the exercise capacity in COPD-patients performing a vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a rehabilitation program.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
- Chronic obstructive pulmonary disease III/IV
- Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
- Severe disease other than COPD, that could influence the results of the study
- Abuse of alcohol or drugs
- Simultaneously participation in another study
- Tachypnea (>30/min)
- Severe exacerbation during rehabilitation
- Cardiac insufficiency (NYHA IV)
- Myocardial infarction during the last 6 weeks
- Mental-health problem
- Pregnancy
- Known HIV-infection
- Slipped disk
- Acute discopathy
- Acute thrombosis
- Implants in trained regions of the body (lower extremities)
- Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis
- Acute tendinopathy in trained regions of the body
- Acute hernia
- Fresh fractures, wounds or scars in trained regions of the body
- Gallstones or stones in the urinary tract collection system
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Rehabilitation with vibration training whole body vibration training -
- Primary Outcome Measures
Name Time Method 6-Minute-Walking-Distance day 1, day 19 Change in 6-minute-walking-distance from baseline to day 19
- Secondary Outcome Measures
Name Time Method Isometric Maximum Handgrip Force day 1, day 19 change in isometric max. handgrip force from baseline to day 19
Arterial Blood Gas day 1 Brain Natruretic Peptide (BNP) day 1, day 19 change in BNP from baseline to day 19
BODE-Score day 1, day 19 Change in Bode-Score from baseline to day 19
Body Composition day 1 and 19 Change in body composition from baseline to day 19
Lung Function day 1
Trial Locations
- Locations (1)
Schön Klinikum Berchtesgadener Land
🇩🇪Schönau am Königssee, Germany